Piedmont Medical Care Corporation Expands Its Use of NextGen® Technology

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of ambulatory healthcare and connectivity solutions, today announced that Piedmont Medical Care Corporation (PMCC), the administrative arm of the non-cardiology physician practice entities of Piedmont Healthcare (PHC), has purchased an additional 230 "bundled” NextGen Electronic Health Record (EHR) and NextGen Enterprise Practice Management (EPM) software licenses. PMCC has utilized NextGen EPM since 2000 and NextGen EHR since 2004, and is currently deploying the NextMD® patient portal. The organization cites its pursuit of financial incentives available through the American Recovery and Reinvestment Act (ARRA) as a reason for expanding its use of NextGen technology.

"We believe technology is the key to developing a truly integrated environment for care delivery, and we are committed to pursuing a strategy of clinical integration among all physician members,” said Ronnie Brownsworth, M.D., CEO of the Piedmont Clinic and executive vice president of Piedmont Healthcare. "The NextGen platform is a critical component of this strategy, and it also provides us with the functionality needed to meet meaningful use criteria and, ultimately, receive stimulus reimbursements.”

Since implementing NextGen EPM, PMCC has realized the following benefits:

• Increased physician income and gross collection rates;
• Near total elimination of errors and a reduction in associated costs;
• 75 percent reduction in patient calls to the central billing office (CBO);
• 70 percent decrease in claim denials; and
• 66 percent reduction in average days in A/R.

PMCC has leveraged NextGen EHR to identify potential drug-to-drug interactions and increase physician awareness of timing for critical screenings. In addition, the organization is using practice and provider feedback reports within NextGen Healthcare’s Health Quality Measures (HQM) Portal to analyze performance against Bridges to Excellence measures for improved patient care and EHR documentation processes.

"Federal incentives coupled with our push for clinical integration has created a ‘perfect storm’ for PMCC,” said Berney Crane, CEO of PMCC. "It is critical for us to jump on this opportunity and take a leadership position in the market. We feel that NextGen Healthcare provides the platform needed to do that.”

About NextGen Healthcare

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), provides integrated electronic health record and practice management systems, connectivity solutions, and billing services for hospitals and ambulatory practices of all sizes and specialties. For more information about NextGen, please visit www.nextgen.com and www.qsii.com.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems' periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.